CNR1 and type 2 diabetes mellitus: Previous findings indicate that the endocannabinoid system plays a critical role in gene expression of cannabinoid receptor type 1 (CB1; also known as CNR1) in the β pancreatic islets and other tissues [2], suggesting a role of the endocannabinoid system in some metabolic diseases, such as type 2 diabetes mellitus.